Breaks Categories: News

FridayFeb 12, 2021 10:37 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Responds to Acquisition Claims Regarding HemPoland

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organically grown cannabis, has released a statement in response to claims of an offer to acquire HemPoland, the company’s wholly owned subsidiary. "There is growing interest in the European CBD market, and several companies have demonstrated interest in acquiring HemPoland as a way of increasing their value and entering this burgeoning market,” the TGOD statement reads. “TGOD receives enquiries and offers about HemPoland on a regular basis, including recently from Labocanna SA. With the hemp industry continuing to expand at a rapid pace, especially in Poland , such…

Continue Reading

FridayFeb 12, 2021 10:06 am

CannabisNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) Execs Appear on Leading Cannabis Investing Podcast

HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) co-founder and CEO Dr. Jason Mitchell and chief corporate officer Danny Brody were featured on a recent segment of the Cannabis Investing Podcast. The program provides actionable investment insight, context with which to understand the burgeoning cannabis industry, and interviews with C-level executives, scientists, law and sector experts. During their segment, Mitchell and Brody discussed highlights in the cannabis industry, including the recent multibillion deal between GW Pharma and Jazz Pharmaceuticals, as well as radical transparency, the industry’s methodical growth and how companies can become more efficient during COVID-19. They also discussed…

Continue Reading

ThursdayFeb 11, 2021 12:37 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Announces National Supply Agreement with CannMart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), a leading producer of premium certified organically grown cannabis, has signed a supply agreement with CannMart, a subsidiary of Namaste Technologies Inc. The two-year agreement means TGOD’s certified organic medical cannabis products will be available via CannMart's online medical cannabis sales platform and further expands the company’s distribution within the medical market. TGOD certified-organic, medical cannabis products included in the agreement include premium dried flower, RIPPLE dissolvable powder, gummies and teas. The announcement also noted that the agreement provides opportunities for future growth as the medical market in Canada evolves and grows.…

Continue Reading

WednesdayFeb 10, 2021 12:54 pm

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Releases Q3 Financial Report

Canopy Rivers (TSX: RIV) (OTC: CNPOF), an investment and acquisition company specializing in cannabis, has shared financial numbers for its most recent period, the three and nine months ended Dec. 31, 2020. The announcement included both unaudited condensed interim consolidated financial statements and management's discussion and analysis ("MD&A"). Numbers in the report indicate that Canopy Rivers’ comprehensive income was $82.2 million, which the company notes was driven by an increase in the value of its investment in TerrAscend. The company also announced a “transformative and accretive” transaction with Canopy Growth; the transaction is scheduled to close by the end of February…

Continue Reading

WednesdayFeb 10, 2021 10:07 am

CannabisNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces First Commercial Contract for CBD Oil

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company specializing in cannabis, hemp and mushroom products, has contracted for its initial commercial CBD oil sale. The company anticipated the contract will result in multiple shipments of its 85% pure CBD distillate offering this year. Pure Extracts’ state-of-the-art, subcritical/super-critical CO2 extraction system produces an exceptionally pure THC and CBD full-spectrum oil and distillate. The resulting distillate can be used to manufacture a variety of cannabis 2.0 products, such as beverages, edibles and vape pens. The announcement also noted that Pure Extracts continues its commitment to increase awareness.…

Continue Reading

TuesdayFeb 09, 2021 11:17 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Releases Preliminary Q4 2020 Revenue, Forecast Numbers

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organically grown cannabis, has announced its Q4 2020 preliminary, unaudited revenue numbers. According to the release, the company reached $10.9 million in unaudited gross revenue in Q4 2020 for the period, with an increase in quarter-over-quarter revenue of 91%. The company also released an updated revenue forecast. The Q4 revenue is a 235% increase over the previous year. In the announcement, the company noted that the numbers reflect the significant progress and growth achieved in its Canadian operations and sales, which accounted for $8.6 million of the…

Continue Reading

ThursdayFeb 04, 2021 10:06 am

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces CannRX Biosciences Partnership

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a U.S.-based cannabis and hemp-branded products company, has entered into a partnership with CannRx Biosciences (“CannRx”). Based in Tel Aviv, CannRX is a leading Israeli cannabis firm focused on the development cannabis-based botanical medicine. The partnership involves using CannRx’s proprietary onset technology, CannTrap, which is a solid nano-particle, water-soluble technology that uses proteins to increase the bioavailability of cannabinoids and terpenes. CannRx works by replicating the body’s sophisticated, protein-based transport system to facilitate improved delivery of active compounds throughout the body; CannRx developed the technology for specific use with cannabinoids. The partnership calls for…

Continue Reading

WednesdayFeb 03, 2021 12:09 pm

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) to Hold Extraordinary Meeting of Debentureholders

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp-branded products company in the United States, has announced an upcoming shareholder meeting. The meeting, scheduled for 10 a.m. ET on Feb. 25, 2021, is an extraordinary meeting of holders of 8% unsecured convertible debentures that are due Feb. 28, 2021. Information containing detailed information regarding the amendments and resolutions to be considered during the meeting has been mailed to the company’s debentureholders of record. The meeting will be held virtually to maintain COVID-19 social distancing requirements; participants will be attending via a telephone conference. The announcement noted that the company’s…

Continue Reading

WednesdayFeb 03, 2021 11:50 am

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Publication of Article Led by CEO Dr. Roger McIntyre

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) today announced the publication of an article led by its CEO Dr. Roger McIntyre. The article, titled, “The Rapid Mood Screener (‘RMS’): a novel and pragmatic screener for bipolar I disorder,” is published at Taylor and Francis.com. "Timely and accurate diagnoses are precursors of good clinical outcomes in persons with treatment-resistant mood disorders, the high rate of missed bipolar disorder diagnosis is a critical unmet need," stated Dr. Roger McIntyre. "The Rapid Mood Screener provides a systematic approach to screening for bipolar disorder amongst all patients who present with depressive symptoms. It…

Continue Reading

WednesdayFeb 03, 2021 11:12 am

CannabisNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Signs Production Agreement with Applied Pharmaceutical Innovation

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, announced that it has signed an agreement with Applied Pharmaceutical Innovation. A not-for-profit institution at the University of Alberta, Applied supports translational drug development for industry and innovators. XPhyto’s psychedelic pharmaceutical production agreement calls for the synthesis of pharmaceutical-grade psychedelic compounds and the development of the standard operating procedures required to obtain regulatory approval for the commercial production process. As part of its psychedelic pharmaceutical program, XPhyto needs industrial-scale production of standardized active pharmaceutical ingredients. This agreement is part of that strategic…

Continue Reading